NCT07138508View on ClinicalTrials.gov

Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 10, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

March 1, 2025

Conditions
No Reflow PhenomenonAnterior STEMI
Interventions
DRUG

Nicorandil 20mg

Oral nicorandil 20mg

Trial Locations (1)

Unknown

Ain shams University hospitals, Cairo

All Listed Sponsors
collaborator

Misr University for Science and Technology

OTHER

lead

Ain Shams University

OTHER

NCT07138508 - Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI | Biotech Hunter | Biotech Hunter